OB/GYN 1009 - OB/GYN Clinical Alert - Sep 01, 2006

Target Audience:

This activity is intended for the obstetrician and gynecologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Leon Speroff, MD
Professor of Obstetrics and Gynecology
Oregon Health and Science University

Peer Reviewer
Catherine Leclair, MD
Assistant Professor
Department of OB/GYN
Oregon Health and Science University

Associate Editors
Frank Ling, MD
Clinical Professor
Dept. of Obstetrics and Gynecology
Vanderbilt University School of Medicine

Robert L. Coleman, MD
Associate Professor
University of Texas; M.D.
Anderson Cancer Center

John C. Hobbins, MD
Professor and Chief of Obstetrics
University of Colorado Health Sciences Center


  • Estrogen, Testosterone, and Breast Cancer in the Nurses' Health Study
  • OB/GYNs' Attitudes Toward Hysterectomy
  • New Light on the Link Between Chronic Stress and Ovarian Cancer Tumorigenesis
  • Managing Poor Response to Hormone Therapy
  • The Peritoneum—To Close or Not to Close During a Cesarean Section?
  • Breast Cancer Risk in the WHI Estrogen-Progestin Trial Arm


  • To present the latest data regarding diagnosis and treatment of various diseases affecting women, including cancer, sexually transmitted diseases, and osteoporosis
  • To present new data concerning prenatal care and complications, as well as neonatal health
  • To discuss the pros, cons, and cost-effectiveness of new testing procedures

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Leon Speroff, MD, is a consultant for Barr Laboratories and does research for Wyeth.

Peer Reviewer Catherine Leclair, MD, Associate Editors Frank W. Ling, MD, and John C. Hobbins, MD report no financial relationship to this field of study.

Associate Editor Robert L. Coleman, MD is on the speaker’s bureau for GlaxoSmithKline, Bristol-Myers Squibb, and Ortho Biotech.

Copyright 2006 AHC Media. All rights reserved.